CDK4/6 Inhibitors for Hormone Receptor-Positive HER2-negative Metastatic Breast Cancer: Does One Size Fit All?
Future Medicinal Chemistry - United Kingdom
doi 10.4155/fmc-2018-0389
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Future Science Ltd